Appointment New Patient Appointment or 214-645-8300

More Blogs


Raksha Jain, M.D.

Landmark cystic fibrosis clinical trial gives patients hope for healthy pregnancies

TRIKAFTA may give patients with cystic fibrosis hope for healthy pregnancies. Learn about the landmark clinical trial to analyze its safety from pregnancy through two years after delivery.

More men are dying from COVID-19 – hormones may be partly to blame

More men are dying from COVID-19, and testosterone may be part of the explanation. In this MedBlog, Raksha Jain, M.D., who researches sex hormones and their affect on infection, discusses the underlying causes of men's risk factors.

Cystic fibrosis breakthrough: 3-drug combo pill may benefit 90% of patients

A new 3-drug combo drug for cystic fibrosis has been approved by the FDA. TRIKAFTA offers life-changing treatment potential for approximately 90% of patients with the disease. In this MedBlog, discover who is eligible and how the drug works. Learn more.

Beyond the lungs: How CFTR modulators benefit cystic fibrosis patients

Traditionally, patients with cystic fibrosis have been treated with inhaled medications that could affect the lungs with limited systemic effects. However, a relatively new set of drugs, CFTR modulators, offer an oral alternative with the potential to slow the progression of the disease for up to 90 percent of patients.